In post-AFib ablation patients with a retroperitoneal bleed requiring transfusion, when should oral anticoagulation be restarted?

There is no easy answer. Much of the decision will depend on the cause of the bleed (e.g., spontaneous versus iatrogenic), the patient's comorbidities and bleeding risk scores, the indication for oral anticoagulation (OAC), and the availability of alternatives such as left atrial appendage occlusion (LAAO) devices. The most important element is close consultation with surgeons and hematologists with regard to prognosis and likelihood of recurrence. This is another example of integrative medicine...

I need more clinical information: hemoglobin (Hb), CHA₂DS₂-VASc score, and timing of recent atrial fibrillation (AF) treatments.

When H/H has been stable, without dropping for 3 consecutive days.